The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer

• Main Authors: Yue Pan (Author), Yucheng Fu (Author), Yue Zeng (Author), Xiaohan Liu (Author), Yurong Peng (Author), Chunhong Hu (Author), Chao Deng (Author), Zhenhua Qiu (Author), Jian Zou (Author), Yuxuan Liu (Author), Fang Wu (Author)
• Format: Book
• Published: BMC, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Immunotherapy has become the standard of care for non-small cell lung cancer (NSCLC), either in combination or monotherapy. However, there are still some patients who cannot benefit from it. Immunization strategies for NSCLC are based on the expression of PD-L1 on tumor cells and TMB, and a...